Health economics is the discipline of economics applied to the topic of health care. Broadly defined, economics concerns how society allocates its resources among alternative uses. Health economics addresses questions primarily from the perspective of efficiency, maximising the benefits from available resources or ensuring benefits gained exceed benefits forgone. This presentation covers the concept, components, importance, factors influencing, steps and various types of evaluation in health economics.
Health economics is the discipline of economics applied to the topic of health care. Broadly defined, economics concerns how society allocates its resources among alternative uses. Health economics addresses questions primarily from the perspective of efficiency, maximising the benefits from available resources or ensuring benefits gained exceed benefits forgone. This presentation covers the concept, components, importance, factors influencing, steps and various types of evaluation in health economics.
Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behaviour in the production and consumption of health and health care.
In broad terms, health economists study the functioning of health care systems and health- affecting behaviour such as smoking.
It is the discipline of economics applied to the health care.
Health Economics is the science of assessing cost and benefits of health care therapies and service. HE is about making choices between options, when there is scarcity of resources.
Health Economics and Health Finance :Jordan Health Policy Directions Musa Ajlouni
This presentation includes general introduction to health economics,the concept of market failure in health, health financing including health insurance and major challenges related to healthcare financing in Jordan and some policy directions to face these challenges.
This presentation gives a basic introduction to the field of health economics and includes important concepts like that of efficiency, equity, opportunity costs, demand and supply and also includes financial evaluation
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Health economics is a branch of economics concerned with issues related to efficiency, effectiveness, value and behaviour in the production and consumption of health and health care.
In broad terms, health economists study the functioning of health care systems and health- affecting behaviour such as smoking.
It is the discipline of economics applied to the health care.
Health Economics is the science of assessing cost and benefits of health care therapies and service. HE is about making choices between options, when there is scarcity of resources.
Health Economics and Health Finance :Jordan Health Policy Directions Musa Ajlouni
This presentation includes general introduction to health economics,the concept of market failure in health, health financing including health insurance and major challenges related to healthcare financing in Jordan and some policy directions to face these challenges.
This presentation gives a basic introduction to the field of health economics and includes important concepts like that of efficiency, equity, opportunity costs, demand and supply and also includes financial evaluation
students wonder exactly what health economics is. is it about money in health, more health for the same money ? about health in hospitals or health of the country.
Lung cancer, which accounted for 1.8 million cases in 2012, is a serious issue in Asia. While it is primarily driven by smoking, non-smoking lung cancer is also growing due to pollution and oncogenic mutation.
Find out more about the severity of lung cancer in China, Taiwan, India, and Korea in our latest Social Innovation Playbook Series on SlideShare
Environmental Health:Economic Costs of Environmental Damage And Suggested Pri...No to mining in Palawan
Environmental Health:
Economic Costs of Environmental Damage
And Suggested Priority Interventions
A Contribution to the Philippines
Country Environmental Analysis
Submitted to
The World Bank
Final Report
March 31, 2009
The results indicate that the economic costs of pollution and sanitation-related
health effects are high and cannot be ignored. The combined costs for all three sectors in 2003 totaled PhP 42.4 billion (USD 783.2 million) in lost productivity due to premature deaths or PhP 168.4 billion (USD 3.1 billion) in terms of value of statistical life (Table1). In addition, the cost of morbidity was PhP 18.3 billion (USD 337.6 million), comprising of loss in productivity totaling PhP 10.4 billion (USD 191.3 million), direct costs to Filipino households to treat these illnesses totaling PhP 6.4 billion (USD 118.7 million), and the cost to the government health care insurance system—representing the subsidy for PhilHealth members’ hospitalization costs—and for general government subsidy for publicly-owned health facilities was close to PhP 1.5 billion (USD 27.6 million).
APIFARMA, the Portuguese pharmaceutical industry assocation, holds a series of conference throughout they year. OHE's Jorge Mestre-Ferrandiz, an expert on pricing and reimbursement (P&R) in Europe, was the lead speaker at the October 2014 conference on access to innovation. His presentation covers existing and potential approaches to evaluating new medicines as a condition for P&R in France, Germany and the UK.
Looking at implementation: how useful is realist evaluation?valéry ridde
Presentation by Emilie Robert (McGill University).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Health system strengthening – what is it, how should we assess it, and does i...ReBUILD for Resilience
This presentation was given to the UK's Department for International Development on 30th July 2019.
Comprehensive reviews of health system strengthening interventions are rare, partly because of lack of clarity on definitions of the term but also the potentially huge scale of the evidence. In our talk, we will reflect on the process of undertaking such an evidence review for DFID recently (attached again), drawing out suggestions on definitions of HSS and approaches to assessment, as well as summarising some key conclusions from the current evidence base. Most HSS interventions have theories of change relating to specific system blocks, but more work is needed on capturing their spill-over effects and their contribution to meeting over-arching health system process goals. We will make some initial suggestions about such goals, to reflect the features that characterise a ‘strong health system’. We will highlight current findings on ‘what works’ but also that these are just indicative, given the limitations and biases in what has been studied and how, and argue that there is need to re-think evaluation methods for HSS beyond finite interventions and narrow outcomes. Clearer concepts, frameworks and methods can support more coherent HSS investment.
Evidence on Improving Health Service Delivery in Developing CountriesIDS
This presentation by David Peters of the Future Health Systems Consortium was given at the Global Symposium on Health Systems Research in November 2010.
HCM 3305, Community Health 1 Course Learning Outcom.docxaryan532920
HCM 3305, Community Health 1
Course Learning Outcomes for Unit VIII
Upon completion of this unit, students should be able to:
3. Recognize effective organization and promotion of health programming for community health on a
global scale.
3.1. Assess the steps for organizing a community health program.
3.2. Identify steps needed to effectively evaluate the community health program.
Reading Assignment
Chapter 15:
Systems Thinking and Leadership in Community and Public Health
Unit Lesson
In this unit, we will discuss systems thinking and community health programming.
Community organizing is a process that involves the engagement of individuals, groups, and organizations.
Program planning is not required in community organizing; however, it is often times used. Program planning
is a process where a health intervention is planned to meet the needs within a population. Antiviolence
campaigns and stress management courses are examples of program planning (McKenzie, Pinger, & Kotecki,
2012).
When deciding which community health interventions to create, the Centers for Disease Control and
Prevention (CDC) uses Guide to Community Preventive Services (Community Guide). The Community Guide
is considered credible because it is based off the scientific systematic review process. The guide answers
many questions that are critical to community health on subjects such as
interventions that have worked/did not work,
populations in which the intervention worked/did not work,
cost of the intervention,
benefits/risks of the intervention, and
future research recommendations (Centers for Disease Control and Prevention, 2015).
Community health programs are intricate and are a key factor in disease prevention, improving health, and
increasing quality of life. Health status and behaviors are determined by personal, environmental, policy, and
organizational influences. Community health programming is targeted at reaching the goals of Healthy People
2010. Community health programs are generally held within healthcare settings; however, other settings are
becoming more popular. Programs are being held at schools, worksites, religious organizations, and within
communities (Healthy People 2020, 2015). There are instances where healthcare organizations are
collaborating with schools to offer health programs. For instance, nutrition and exercise programs are being
offered at an increased rate. Employers see the value of employee health. Therefore, many employers offer
incentives to employees who take part in employee wellness programs. It is not far fetched to hear about
employers checking cholesterol, blood pressure, quality of life, weight, BMI, and sometimes glucose. The
rationale is that healthy employees are less likely to call in sick with health-related conditions.
Community health professionals must identify their health issue, and then create specific and measurable
goals and objectives. ...
The Contextualizing Guidance Workbook can help you consider factors from the broader health system and political system so you make the most appropriate policy recommendations and decisions. Find out how this tool can help you apply recommendations from a guidance document to address the issue/problem in your local context:
View our summary of this resource here: http://www.nccmt.ca/resources/search/238
NCCMT is one of six NCCs for Public Healthh in Canada More on the NCCs at www.nccph.ca Production of this webinar has been made possible through a financial contribution from the Public Health Agency of Canada. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.
· Justify the value of marketing plans as instruments that compel .docxoswald1horne84988
· Justify the value of marketing plans as instruments that compel marketers to think about upcoming periods, perform routine marketing analyses and audits, and set marketing goals and objectives such as Return on Investment (ROI), etc. Provide one (1) example of the use of marketing plans in this fashion to support your rationale.
· Decide whether or not you believe Philip Kotler’s Marketing Plan Model provides a useful framework for developing an effective marketing plan. Provide at least two (2) specific examples of the Philip Kotler’s Marketing Plan Model that apply within a health care organization with which you are familiar.
Appendix C
Criteria of evaluation of health reform
CRITERIA
*4
3
2
1
0
Comments
I. introduction description of topic / subject selected with relationship to the situation current in the services of health.
Discussion of the methodology of work to develop the theme.
II. conceptual framework of evaluation use literature to support the approach selected for evaluation.
Provides the frame concept.
III.main findings of the analysis and interpretation of data collected by the group what is the current situation? What are the main features of the health system of the State of Florida or U.S.
What problems are there, according to the perception of different interest groups?
Previous studies with conclusive and irrefutable information? What are its main findings and conclusions?
There are significant differences between different approaches to participating insurers? It varies markedly rules and procedures and the indicators of performance of the existing approaches? What are the differences in covers and costs of private and Government health insurance plans?
¿ What options there are for them people not insured that does not qualify for the Plan of health of the Government and not can pay a Plan private?
What is the satisfaction of the various providers and consumers, with the current system?
¿ How effective have the solutions tested in the past been?
¿ What are the main weaknesses of the current system?
¿ What are the key strengths that we want to keep?
How does it compare the situation of the health system of the State of Florida or the nation with that of other countries?
INSTRUCTION FOR PUBLIC HEALTH POLICIE, ETHIC AND SYSTEMS. 5 pages.
N
URS 501 Public Health Policies, Ethics and Systems 4
Prepared: 11/15/2012
Prepared: 11/15/2012
Prepared: 11/15/2012
N
URS 501 Public Health Policies, Ethics and Systems 93
Criteria
*4
3
2
1
O
N/A
Comments
¿ What conclusions can we arrive on the effects of the current health system? What results in the health of the population and of the performance of the system of health allow conclude on the need of change?
¿ There is consensus in key areas to improve? Could one achieve consensus and commitment to the recommendations of the Group?
IV. determina.
This article introduces health care managers to the theories and philosophies of John Kotter and William Bridges, 2 leaders in the evolving field of change management. For Kotter, change has both an emotional and situational component, and methods for managing each are expressed in his 8-step model (developing urgency, building a guiding team, creating a vision, communicating for buy-in, enabling action, creating short-term wins, don't let up, and making it stick). Bridges deals with change at a more granular, individual level, suggesting that change within a health care organization means that individuals must transition from one identity to a new identity when they are involved in a process of change. According to Bridges, transitions occur in 3 steps: endings, the neutral zone, and beginnings. The major steps and important concepts within the models of each are addressed, and examples are provided to demonstrate how health care managers can actualize the models within their health care organizations.
Similar to A methodological framework for developing the structure of Public Health economic models (20)
Do height and BMI affect human capital formation? Natural experimental evidence from DNA. CHE seminar presentation by Neil Davies, University of Bristol 12 June 2020
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...cheweb1
CHE Seminar presentation 16 January 2020, Alistair McGuire, Department of Health Policy, LSE. Evaluating the Healthy Minds program: The impact on adolescent’s health related quality of life of a change in a school curriculum
Baker what to do when people disagree che york seminar jan 2019 v2cheweb1
Public values, plurality and health care resource allocation: What should we do when people disagree? (..and should economists care about reasons as well as choices?) CHE Seminar 21 January 2019
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
A methodological framework for developing the structure of Public Health economic models
1. A methodological framework
for developing the structure
of Public Health economic
models
Dr Hazel Squires, ScHARR, University of Sheffield
Prof. Jim Chilcott, Prof. Ron Akehurst,
Dr. Jennifer Burr, Prof. Mike Kelly
2. Introduction
• Why we need a conceptual modelling framework
specific to Economic Modelling in Public Health
(PHE)
• Methods for developing the PHE conceptual
modelling framework
• An outline of the PHE conceptual modelling
framework
• Conclusions
3. Background
• Healthcare agencies such as the National
Institute for Health and Care Excellence (NICE)
need to decide how to spend their money.
• Mathematical models are used to provide a
rational, coherent & transparent framework of
the cost-effectiveness of healthcare
interventions.
• Inappropriately simple models and lack of
justification may lead to poor validity and
credibility, resulting in suboptimal allocation of
resources.
4. Current methods for dealing
with structural uncertainty
1) Retrospective: following model implementation
by expressing the impact of uncertainties upon
the model results.
• Scenario analysis
• Model averaging
2) Prospective: considering the process through
which decisions are made around the
conceptualisation, structuring and
implementation of the model.
• Model development practice in health economics is
extremely varied (Chilcott, 2010).
Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S et al. Avoiding and identifying errors in health
technology assessment models: qualitative study and methodological review. Health Technol Assess 2010; 14(25).
5. What is a Conceptual
Modelling (CM) Framework?
• ‘A set of steps that help to guide modellers
through the development of a model structure,
from developing and describing an
understanding of the decision problem to the
abstraction and non-software specific
description of the quantitative model, using a
transparent approach which enables each stage
to be shared and questioned.’
Based upon Kaltenthaler E., Tappenden P., Paisley S. and Squires H. Identifying and reviewing evidence to inform the
conceptualisation and population of cost-effectiveness models, No. 14, 2011 and Robinson S. Conceptual
modelling for simulation Part I: definition and requirements. Journal of the Operational Research Society 2008;
59:278-290.
6. Key potential benefits of a
CM Framework
• Aids the development of modelling objectives;
• Provides tools for communication with stakeholders;
• Guides model development and experimentation;
• Improves model validation (developing the right model);
• Improves model verification (developing the model right);
• Allows model reuse;
• Helps to characterise structural uncertainties and identify
primary research needs.
7. Economic evaluation of Public
Health compared with clinical
interventions
• A key objective of Public Health is reduction of health
inequities;
• PH interventions tend to:
- Be multi-component with complex causal chains;
- Operate within dynamically complex systems;
- Be dependent upon human behaviour;
- Be dependent upon the social determinants of health,
requiring consideration of non-health costs & outcomes;
• It is much less clear what a ‘good’ outcome is;
• The culture & politics of the system is important in
choosing & assessing interventions
8. Methods for developing PHE
conceptual modelling framework
1) Literature review of key challenges in PHE modelling
(Squires et al., 2016)
2) Review of conceptual modelling frameworks in broader
literature.
3) Qualitative research to understand modellers’ experiences
with developing the structure of PH economic models &
their views about the benefits/ barriers of using a CM
framework.
4) Pilot of the draft CM framework within a case study of
diabetes screening & prevention.
5) Evaluation via qualitative analysis & theory-based
evaluation.
Squires H, Chilcott J, Akehurst R, Burr J, Kelly M. A systematic literature review of the key challenges for developing the
structure of public health economic models. Int. J. of Public Health. Epub ahead of print.
http://www.ncbi.nlm.nih.gov/pubmed/26747470
9. The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
11. The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
12. The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
13. The CM framework:
Key principles
(1) A systems approach to Public Health modelling should
be taken (feedback loops & unintended consequences
are important);
(2) Developing a thorough documented understanding of
the problem is imperative prior to and alongside
developing and justifying the model structure;
(3) Strong communication with stakeholders and members
of the team throughout model development is essential;
(4) A systematic consideration of the determinants of health
is central to identifying all key impacts of the
interventions within Public Health economic modelling.
14. The determinants of health
Dahlgren G., Whitehead M. Policies and strategies to promote social equity in health. 1991. Institute
for Future Studies, Stockholm.
15. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
16. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
17. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
18. Stakeholders
Stakeholders are identified based upon the
classification from Soft Systems Methodology
(SSM):
• Customers which might include patient
representatives and lay members;
• Actors which might include clinical experts and
epidemiologic experts for all relevant diseases
and methods experts;
• System owners which might include policy
experts (in addition to some of the people
identified as actors).
19. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
20. Example conceptual
model of the problem
Contraception project example:
Why is this a problem?
_ _
Maximise health Minimise costs to NHS & PSS Minimise costs to other sectors
_ _ _ _ _ _ _ _ _
Poor health outcomes of the mother
Low birth weight babies + Poor long term socioeconomic outcomes
+ + +
Miscarriage/ stillbirth Abortion Unwanted teenage birth
+ + +
What is the problem? +
Unintended teenage pregnancies STIs
_ + +
Poor contraceptive use by sexually active teenagers
(interaction between a male & female)
+ +
Disadvantaged background
Competing risks
Dependent on history & timing of STIs
21. Questions to help develop
diagram: The disease &
determinants of health
• Have any relevant disease natural histories been
captured?
• Are the following determinants of health important in
determining outcomes & in what way:
• Age, sex & other inherent characteristics of the population of
interest?
• Individual lifestyle factors?
• Social and community networks?
• Living & working conditions & access to essential goods &
services?
• General socioeconomic, cultural & environmental conditions?
22. Questions to help develop
diagram: Dynamic complexity
• Are there any other (positive or negative)
consequences of each concept?
• Are there any other possible causal links
between the factors? (to establish whether there
are any feedback loops)
• Could there be any other factors which explain
both of these outcomes, for links which may not
be causal, but correlated?
• Are there interactions between different sets of
people?
• Is timing/ ordering of events important?
23. Questions to help develop
diagram: Intervention outcomes
• What is a good outcome?
• What would happen in the absence of the
interventions versus as a result of the interventions
– would behaviour be prevented or delayed?
• What evidence exists to describe the outcomes of
the intervention/ comparator over time? Are
behavioural outcomes important?
• Are there any determinants of health reported by
the effectiveness studies which are not included
within the causal diagram? Can such a relationship
be described?
24. Questions to help develop
diagram: Dynamic complexity
of interventions
• Might a third party act to reduce or increase the
impact of interventions?
• Are there any substantial impacts of social and/or
community networks upon intervention
effectiveness? Will these impacts be captured over
the long term within the effectiveness evidence?
• Are there any substantial impacts of the
interventions upon other lifestyle factors?
• Might the interventions have other impacts not
already considered?
25. Sources of evidence
Starting with high
yield sources
Individual stakeholder
assumptions & beliefs
Stakeholder
discussion
Modeller assumptions
& beliefs
Project scope
Literature
sources
Existing diagrams/
previous work
Conceptual model of the problem
26. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
27. CM framework overview
Aligning the framework with
the decision making process
Identifying relevant
stakeholders
Understanding the problem
i) Developing a conceptual model of the problem
ii) Establishing resource pathways
Developing and justifying the model structure
i) Reviewing existing economic evaluations
ii) Choosing specific model interventions
iii) Determining the model boundary
iv) Determining the level of detail
v) Choosing the model type
vi) Developing a qualitative description of the quantitative model
28. Develop understanding of the
problem
Assess whether there is
an existing model which
could be employed
Identify strengths &
limitations of different
model structures
Identify strengths &
limitations of different
model types
Identify key variables which
generally affect model results
(incl. any not already
identified) & key variables
included within the causal
diagram which do not
Identify the sort
of data available
Identify factors with not many
causal links & assess whether
they would have a substantial
impact upon the difference
between outcomes of
interventions & comparators
Identify types of
outcomes reported
Identify long term
evidence & mechanisms
Describe effectiveness of
interventions (to help
choose which to model
& for parameterisation)
Model boundary Model detail Model type
Discuss potential model perspectives,
outcomes, interventions &
populations with stakeholders
Review existing health
economic models
Review effectiveness of
relevant interventions
Review evidence of
relationships between factors
29. Does the factor have many causal links?
Yes No
Is the factor likely to have a substantial
impact upon the difference between costs &
effects of the interventions? This may be
based upon (though not limited to):
(1) the review of economic evaluations;
(2) the description of resource pathways;
(3) clinical papers describing the causal links;
(4) existing models in similar areas which
describe the impact of the factor;
(5) methodological choices eg. discounting;
(6) expert advice.
Yes No
INCLUDE
Is the factor associated with the interventions,
populations & outcomes being modelled?
EXCLUDE
INCLUDE
EXCLUDE
Yes No
Yes
Is the impact of the factor predominantly
captured by other included factors?
Yes
EXCLUDE
No
Would stakeholders prefer to
include the factor for model
credibility AND is it relatively easy
to incorporate in terms of
modelling skill & data availability?
INCLUDE
No
Will the model only assess one intervention AND
is the intervention likely to be cost-effective AND
does the factor only further increase benefits
Yes
No
Determining
the model
boundary
31. Determining level of detail
Key types of model assumptions/ simplifications:
1. The relationship between the included factors over time;
2. The extrapolation of study outcomes;
3. The level of detail used to describe each included factor;
4. How interventions will be implemented in practice.
Questions to help the modeller for each of these are
proposed within the framework.
32. Choosing model type (1)
A B C D
Cohort/ aggregate level/ counts Individual level
Expected value,
continuous state,
deterministic
Markovian, discrete
state, stochastic
Markovian, discrete
state
Non-Markovian,
discrete state
1 No
interaction
Untimed Decision tree
rollback
Simulation decision
tree
Individual sampling model: Simulated
patient-level decision tree
2 Timed Markov model
(deterministic)
Simulation Markov
model
Individual sampling model: Simulated
patient-level Markov model
3 Interaction
between
entity and
environment
Discrete
time
System dynamics
(finite difference
equations)
Discrete time
Markov chain
model
Discrete-time
individual event
history model
Discrete individual
simulation
4 Continuous
time
System dynamics
(ordinary
differential
equations)
Continuous time
Markov chain
model
Continuous time
individual event
history model
Discrete event
simulation
5 Strong interactions
between entities. Spatial
aspects important.
X X X Agent-based
simulation
Revised version of taxonomy by Brennan A, Chick SE, Davies R. A taxonomy of model structures
for economic evaluation of health technologies. Health Econ 2006; 15(12):1295-1310.
33. Choosing
model type
(2)
Determine the most appropriate model type for the characteristics of the problem.
Is this feasible within the time and resource constraints of the decision making process given:
(i) the data available?
AND
(ii) the accessibility of any existing relevant good quality economic evaluations for use as
a starting point?
AND
(iii) the expertise of the modeller?
Are you intending to use the
model again for other
projects?
Can you answer the decision makers’ question
with a few provisos and uncertainties with a
simpler model type?
Yes No
Explore with the
decision maker the
most useful purpose of
the modelling given the
project constraints
Develop the simpler model
type, documenting the
provisos, uncertainties &
implications of the
simplifications
NoYes
Do you think a
simpler model type
would lead to the
same conclusions?
Develop
the
model
Yes No
Develop the more
complex model
Develop the simpler model,
documenting the provisos,
uncertainties & implications
of the simplifications
Yes No
34. Conclusions
• Very little research has been undertaken
around conceptual modelling in health
economic evaluation.
• We have developed a conceptual modelling
framework for use within Public Health
economic models (paper under review).
• This has yet to be tested on a range of case
studies.
• If anybody wants to know more about the
framework or potentially use it, let me know!
Email: h.squires@sheffield.ac.uk
PhD thesis: http://etheses.whiterose.ac.uk/5316/